Dr. Guy Raoul Rosenschein, MD Surgery - Pediatric Surgery Medicare: Not Enrolled in Medicare Practice Location: 5230 Willow Creek Dr, Suite 201, Springdale, AR 72762 Phone: 479-927-3100 Fax: 479-927-3131 |
Sabina M Siddiqui, MD Surgery - Surgical Critical Care Medicare: Medicare Enrolled Practice Location: 2601 Gene George Blvd, Springdale, AR 72762 Phone: 479-725-6800 |
Dr. Jeffrey Allen Swetnam, MD Surgery Medicare: Medicare Enrolled Practice Location: 3623 Johnson Mill Blvd Ste 203, Springdale, AR 72762 Phone: 479-966-4174 Fax: 479-301-5334 |
John David Alston, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 724 Deaver St, Springdale, AR 72764 Phone: 479-751-3202 Fax: 479-756-2721 |
Jerry S Dorman, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 724 Deaver St, Springdale, AR 72764 Phone: 479-751-3202 Fax: 479-756-2721 |
Robert A Petrino, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 706 A Quandt Ave, Springdale, AR 72764 Phone: 479-757-2030 Fax: 479-750-6236 |
Dr. John Henry Kendrick, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 5230 Willow Creek Dr, Suite 201, Springdale, AR 72762 Phone: 479-927-3100 Fax: 479-927-3131 |
News Archive
Nevro Corp., a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today announced that it has received a letter from the U.S. Food and Drug Administration informing the company of the approvability of its Premarket Approval Application (PMA) for the Senza spinal cord stimulation (SCS) system.
SciQuest, Inc., a leading provider of on-demand strategic procurement and supplier enablement solutions, was once again named to the Inc. 500|5000 list of the fastest-growing, private companies in America. SciQuest first appeared on the Inc. 500|5000 list in 2007.
In a study to determine how older people progress through different states of frailty, researchers at Yale School of Medicine have found that the physical symptoms that mark frailty are often reversible and therefore amenable to intervention.
People with a rare dementia that initially attacks the language center of the brain recruit other areas of the brain to decipher sentences, according to new research led by a University of Arizona cognitive scientist.
Teva Pharmaceutical Industries Ltd announced today that it has concluded an Asset Transfer Agreement with NeuroSearch A/S of Denmark to purchase all rights, assets and obligations relating to Huntexil (pridopidine / ACR16), a drug candidate being developed for the symptomatic treatment of hand movement, balance and gait disturbances in Huntington disease (HD).
› Verified 9 days ago